1
|
Faris M, Bostancı HE, Özcan İ, Öztürk M, Koçyiğit ÜM, Erdoğan T, Tahtaci H. Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I-II Inhibition Properties, and In Silico Studies. ACS OMEGA 2024; 9:20937-20956. [PMID: 38764643 PMCID: PMC11097166 DOI: 10.1021/acsomega.4c00028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/02/2024] [Revised: 04/16/2024] [Accepted: 04/23/2024] [Indexed: 05/21/2024]
Abstract
Imidazole derivatives display extensive applications in pharmaceutical chemistry and have been investigated as bioactive compounds for medicinal chemistry. In this study, besides the starting materials (3a-c and 4a-c), synthesis, characterization, and biological activity studies were conducted on a total of 18 compounds, nine of which are known and the other nine are original. The compounds investigated in the study are a series of alkyl (7-15) and aryl (16-24) ether derivatives bearing substituted phenyl and imidazole rings, which were characterized using various methods including 1H NMR, 13C NMR, FT-IR analysis, elemental analysis, and mass spectroscopy. Computer-aided drug design studies have been carried out to predict the biological activities of compounds. Besides DFT calculations, the binding affinities of the compounds to EGFR, VEGFR2, FGFR1, HSP90, hCA I, and hCA II were investigated. Additionally, drug-likeness and ADME analyses were performed on the compounds. Anticancer, antioxidant, and enzyme inhibition activity tests were performed in biological activity studies on the synthesized compounds. Among the synthesized compounds, compounds 17 and 19-24 generally exhibited inhibition profiles against the widespread cytosolic hCA I isozyme with IC50 values ranging from 4.13 to 15.67 nM and cytosolic hCA II isozyme with IC50 values ranging from 5.65 to 14.84 nM. L929 (mouse fibroblast cell line) was used as the control healthy cell line, and MCF7 (breast cancer), C6 (rat glioblastoma), and HT-29 (colon cancer) cells were used in cell culture studies as cancer cell lines. Before the study on cancer cells, all compounds were examined on healthy cells, and their cytotoxicity was determined. As a result of these data, studies continued with six compounds determined to be nontoxic. On cancerous cells, it was determined that compounds 3a, 3b, 4a, 4b, 4c, and 7 had cytotoxic effects on both colon cancer and brain tumors. It was found that compound 3b had a more toxic effect than cisplatin on the glioma cell line with an IC50 value of 10.721 ± 0.38 μM, and compound 3a had a more toxic effect on the colon cancer cell line with an IC50 value of 20.88 ± 1.02 μM. However, it was determined that the same compounds did not have a statistically significant effect on breast cancer. Flow cytometry studies also showed that when the IC50 dose of compound 3b was applied to the C6 cell line, the cells tended to early and late apoptosis. Additionally, it has been shown by flow cytometry that the cell cycle stops in the G0/G1 phase. A similar effect was observed in the colon cancer cell line with compound 3a. Compound 3b caused early and late apoptosis of the colon cancer cell line with the applied IC50 dose and stopped the cell cycle in the G0/G1 phase. Finally, the FRAP method studied all synthesized compounds' antioxidant effects. According to the measured antioxidant power results, it was determined that no compound had a more effective reducing power than vitamin E.
Collapse
Affiliation(s)
- Mays Faris
- Department
of Chemistry, Faculty of Science, Karabuk
University, 78050 Karabuk, Türkiye
| | - Hayrani Eren Bostancı
- Department
of Biochemistry Sivas, Faculty of Pharmacy, Sivas Cumhuriyet University, 58010 Sivas, Türkiye
| | - İbrahim Özcan
- Department
of Chemistry, Faculty of Science, Karabuk
University, 78050 Karabuk, Türkiye
| | - Mustafa Öztürk
- Sivas
Vocational School of Technical Sciences, Sivas Cumhuriyet University, 58010 Sivas, Türkiye
| | - Ümit Muhammed Koçyiğit
- Department
of Biochemistry Sivas, Faculty of Pharmacy, Sivas Cumhuriyet University, 58010 Sivas, Türkiye
| | - Taner Erdoğan
- Kocaeli
Vocational School, Department of Chemistry and Chemical Processing
Technologies, Kocaeli University, 41140 Kocaeli, Türkiye
| | - Hakan Tahtaci
- Department
of Chemistry, Faculty of Science, Karabuk
University, 78050 Karabuk, Türkiye
| |
Collapse
|
2
|
Taslimi P, Kocyigit UM, Tüzün B, Kirici M. Biological effects and molecular docking studies of Catechin 5-O-gallate: antioxidant, anticholinergics, antiepileptic and antidiabetic potentials. J Biomol Struct Dyn 2020; 40:2489-2497. [PMID: 33146092 DOI: 10.1080/07391102.2020.1840440] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- Parham Taslimi
- Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
| | - Umit M. Kocyigit
- Department of Basic Pharmaceutical Sciences, Division of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey
| | - Burak Tüzün
- Department of Chemistry, Faculty of Science, Sivas Cumhuriyet University, Sivas, Turkey
| | - Mahinur Kirici
- Department of Chemistry, Faculty of Arts and Sciences, Bingol University, Turkey
| |
Collapse
|
3
|
Koçyiğit ÜM, Gezegen H, Taslimi P. Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease. Arch Pharm (Weinheim) 2020; 353:e2000202. [DOI: 10.1002/ardp.202000202] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2020] [Revised: 07/23/2020] [Accepted: 07/29/2020] [Indexed: 01/28/2023]
Affiliation(s)
- Ümit M. Koçyiğit
- Department of Basic Pharmaceutical Sciences, Division of Biochemistry, Faculty of Pharmacy Sivas Cumhuriyet University Sivas Turkey
| | - Hayreddin Gezegen
- Department of Nutrition and Dietetics, Faculty of Health Sciences Sivas Cumhuriyet University Sivas Turkey
| | - Parham Taslimi
- Department of Biotechnology, Faculty of Science Bartin University Bartin Turkey
| |
Collapse
|